Electrochemically activated chemotherapy (EAC) works because it is paralleling the body's own metabolic enzymes to make a drug in solution more potent on a dose-for-dose basis versus not using EAC.

​

EAC uses a chemotherapeutic galvanostat/potentiostat (CGP), like The Joey™ from Innovative Potential™, to activate a prodrug molecule in one of two ways:

1. by removing a protective group; or,

2. by increasing a molecule's general reactivity.

There are some limitations to EAC but the general rule is that:

• if the prodrug can bioactivate, then EAC will work when the molecule is activated by a CGP, or The Joey™ by Innovative Potential™.

​

What is bioactivation?

Bioactivation is the naturally occurring metabolic process that makes a molecule more reactive so that it can be excreted.

​

You can think of EAC as bioactivation, but instead of it occurring in a cell, a machine like The Joey™ from Innovative Potential™ is doing the activation.

​​​